covid-19
Showing NaN - NaN of 92
Patients Given Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine
Recruiting
- Influenza, Human
- COVID-19
- Comirnaty
- Quadrivalent Influenza Vaccine
-
New York, New YorkPfizer
May 11, 2023
COVID-19 Trial in Worldwide (BRII-196, BRII-198, Placebo)
Completed
- COVID-19
- BRII-196
- +3 more
-
Tucson, Arizona
- +106 more
Mar 24, 2023
COVID-19 Trial in New York (SMARTest mobile app for COVID-19 self-testing)
Recruiting
- COVID-19
- SMARTest mobile app for COVID-19 self-testing
-
New York, New YorkICAP Harlem Prevention Center
Jan 25, 2023
NIH RECOVER Tissue Pathology: Understanding Long-Term Impact of
Recruiting
- COVID-19
- SARS CoV 2 Infection
-
New York, New YorkNYU Langone Health
Jan 25, 2023
Covid-19, Substance Use, Opioid Use Trial in New York (Chain-referral, Credible Messenger)
Completed
- Covid-19
- +2 more
- Chain-referral
- Credible Messenger
-
New York, New YorkNew York State Psychiatric Institute
Jan 19, 2023
Inpatient COVID-19 Treatments
Active, not recruiting
- COVID-19
- Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)
-
New York, New YorkAetion, Inc.
Jan 12, 2023
COVID-19 Trial in New York (Hydroxychloroquine (HCQ))
Completed
- COVID-19
- Hydroxychloroquine (HCQ)
-
New York, New YorkNYU Langone Health
Dec 12, 2022
SARS-CoV Infection, COVID-19, Allergic Reaction Trial in United States (Moderna COVID-19 Vaccine, Pfizer-BioNTech COVID-19
Completed
- SARS-CoV Infection
- +3 more
- Moderna COVID-19 Vaccine
- +2 more
-
Tucson, Arizona
- +28 more
Sep 19, 2022
SARS-CoV2 Infection, COVID-19 Trial in Long Beach, Miami Lakes, New York (IMM-BCP-01, Placebo)
Recruiting
- SARS-CoV2 Infection
- COVID-19
- IMM-BCP-01
- Placebo
-
Long Beach, California
- +2 more
Aug 11, 2022
COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)
Recruiting
- COVID-19
- Ad26.COV2.S
- +4 more
-
Atlanta, Georgia
- +11 more
Aug 11, 2022
COVID-19, Long COVID, Pulmonary Fibrosis Trial in Aurora, New York, Houston (BIO 300 Oral Suspension, Placebo)
Recruiting
- COVID-19
- +4 more
- BIO 300 Oral Suspension
- Placebo
-
Aurora, Colorado
- +3 more
Aug 1, 2022
COVID-19 Quantitative Antibody Titers & Booster Vaccinations
Completed
- COVID-19
- +2 more
- Observational
-
New York, New YorkAHD Manhattan Midtown HCC
Jul 26, 2022
COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)
Completed
- COVID-19
- Lenzilumab
- +2 more
-
Birmingham, Alabama
- +55 more
Jul 21, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in United States (Famotidine,
Terminated
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Newport Beach, California
- +14 more
Jul 20, 2022
CU-COMMITS: COVID-Care in Black and Latino Communities and
Recruiting
- COVID-19
- SARS CoV 2 Infection
- Survey
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Jul 19, 2022
COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)
Active, not recruiting
- COVID-19
- SARS-CoV-2
- AZD1222
- Placebo
-
Phoenix, Arizona
- +83 more
Jul 13, 2022
Transmission of COVID-19 in Households of SARS-CoV-2 Index Cases
Recruiting
- COVID-19
- +2 more
-
New York, New YorkColumbia University Irving Medical Center
Jul 19, 2022